SEC Form 4 · accession 0001571049-17-001290
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas G Dagger
Officer — SVP, Gen Counsel and Corp Secr
Period of report
Feb 9, 2017
Accepted (ET)
Feb 13, 2017 · 8:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Feb 9, 2017 | M | 3,993 | $11.83 | A | 3,993 | D | |
| Class A Common StockF2 | Feb 9, 2017 | M | 1,900 | $11.83 | A | 5,893 | D | |
| Class A Common StockF4 | Feb 9, 2017 | S | 5,893 | $30.27 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Class A Common Stock | $11.83 | Feb 9, 2017 | M | 5,893 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 3,993 | 0 | D |
| Option to purchase Class A Common Stock | $11.83 | Feb 9, 2017 | M | 1,900 | D | Mar 1, 2013 | Feb 28, 2019 | Class A Common Stock | 1,900 | 9,150 | D |
Explanation of responses
- F1Reflects conversions of options with an exercisable date of March 1, 2012.
- F2Reflects conversion of options with an exercisable date of March 1, 2013.
- F3The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2016.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.45.